ABSI Competitors & Alternatives
Compare Absci Corp with similar stocks in the same industry
Biotechnology
ABSI
Main Stock$7.78
Tradestie Score
51
Market Cap
$468.01M
Revenue Growth
-0.8%
Analyst Upside
+77.1%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$19.05
|
$1.35B | - | 59 | Compare |
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$40.98
|
$1.32B | - | 58 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$8.08
|
$1.29B | 120.3 | 60 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$28.86
|
$1.29B | - | 59 | Compare |
|
ARDX
Ardelyx, Inc.
|
$4.95
|
$1.29B | - | 60 | Compare |
|
ZYME
Zymeworks Inc.
|
$21.94
|
$1.28B | - | 49 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$6.33
|
$1.27B | - | 59 | Compare |
|
SION
Sionna Therapeutics, Inc. Common Stock
|
$47.13
|
$1.26B | - | 51 | Compare |
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 58 | Compare |
|
ATAI
ATAI Life Sciences N.V. Common Shares
|
$7.18
|
$1.22B | - | 55 | Compare |
More ABSI Analysis
Data updated: Aug 02, 2026 | Industry: Biotechnology (SIC 8731)
230 stocks in this industry